SDCBP and infection: Nevertheless, our results clearly demonstrates that the treatment of cells with a syntenin inhibitor can be used to inhibit infection of a broad range of enveloped RNA viruses, most likely by blocking the entry through the endosomal pathway, which might suggest a path towards the development of novel antiviral therapeutics.